Irrespective of these limitations, the study provides evidence that the expression of AR-SVs is not limited to CRPC, as previously thought, but could be expressed in primary PCa at a much higher rate and that the expression of AR-SVs in primary PCa might be underestimated clinically. This evidence concerns the gene AR and posterior cortical atrophy.